InBody Co.,Ltd

KOSDAQ:A041830 Stock Report

Market Cap: ₩292.6b

InBodyLtd Past Earnings Performance

Past criteria checks 2/6

InBodyLtd has been growing earnings at an average annual rate of 13.3%, while the Medical Equipment industry saw earnings growing at 22.2% annually. Revenues have been growing at an average rate of 12.8% per year. InBodyLtd's return on equity is 11.9%, and it has net margins of 16.2%.

Key information

13.35%

Earnings growth rate

13.63%

EPS growth rate

Medical Equipment Industry Growth22.66%
Revenue growth rate12.79%
Return on equity11.94%
Net Margin16.21%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings

Nov 12
There's No Escaping InBody Co.,Ltd's (KOSDAQ:041830) Muted Earnings

Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital

Aug 12
Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital

InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Apr 12
InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital

Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Mar 25
Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)

Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Mar 08
Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

Feb 18
Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?

How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 31
How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?

Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

Jan 11
Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?

InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

Dec 17
Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)

InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 02
InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

Nov 17
Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?

Revenue & Expenses Breakdown

How InBodyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A041830 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 24204,46533,143101,96311,170
30 Sep 24191,30431,80794,59610,487
30 Jun 24185,33636,42888,0819,850
31 Mar 24175,75435,17282,3699,091
31 Dec 23170,35136,72378,0549,311
30 Sep 23171,52335,37675,1309,341
30 Jun 23165,66332,52872,9999,176
31 Mar 23164,43134,11269,8729,212
31 Dec 22160,00433,81666,2338,779
30 Sep 22154,92536,46562,3908,719
30 Jun 22149,07534,32958,2918,834
31 Mar 22143,39934,03855,3908,523
31 Dec 21137,83734,03352,4278,062
30 Sep 21128,76231,72950,3646,968
30 Jun 21125,03630,55649,6256,382
31 Mar 21112,33422,62047,3725,529
31 Dec 20107,12217,51847,5665,801
30 Sep 20109,49314,49249,2036,024
30 Jun 20107,80613,55948,9985,535
31 Mar 20116,39319,96949,3585,947
31 Dec 19117,05920,42848,7255,243
30 Sep 19113,40421,16445,1175,324
30 Jun 19110,79122,18743,5295,249
31 Mar 19106,38121,39842,7115,300
31 Dec 1899,63519,67141,3445,211
30 Sep 1898,92521,91839,8915,395
30 Jun 1898,35221,68638,5165,803
31 Mar 1895,33720,57036,8526,293
31 Dec 1793,25419,32234,8867,250
30 Sep 1786,46217,50633,4326,714
30 Jun 1780,00614,85931,5886,463
31 Mar 1776,80614,57429,8295,966
31 Dec 1679,84816,98728,3825,377
30 Sep 1679,95416,85326,5725,400
30 Jun 1680,35619,16525,1365,382
31 Mar 1676,56118,35923,6365,011
31 Dec 1568,94917,31122,8474,882
30 Sep 1561,59413,80218,9597,035
30 Jun 1554,67510,61518,4085,887
31 Mar 1552,0539,30220,8273,923
31 Dec 1448,9408,87919,6833,392
30 Sep 1445,4989,16018,7392,711
30 Jun 1442,9668,36218,2662,540

Quality Earnings: A041830 has high quality earnings.

Growing Profit Margin: A041830's current net profit margins (16.2%) are lower than last year (21.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A041830's earnings have grown by 13.3% per year over the past 5 years.

Accelerating Growth: A041830's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A041830 had negative earnings growth (-9.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.2%).

Return on Equity

High ROE: A041830's Return on Equity (11.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 01:52
End of Day Share Price 2025/05/19 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

InBody Co.,Ltd is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kathy ParkCGS International
null nullDBS Bank Ltd
Jaesong WooHaitong International Research Limited